Patents by Inventor Amaud Glacet

Amaud Glacet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies with enhanced ADCC function
    Patent number: 9718889
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADCC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: August 1, 2017
    Assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Roland Beliard, Dominique Bourel, Amaud Glacet, Christophe De Romeuf, Nicolas Bihoreau, Emmanuel Nony
  • MONOCLONAL ANTIBODIES WITH ENHANCED ADCC FUNCTION
    Publication number: 20150152189
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.
    Type: Application
    Filed: February 9, 2015
    Publication date: June 4, 2015
    Applicant: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Roland Beliard, Dominique Bourel, Amaud Glacet, Christophe De Romeuf, Nicolas Bihoreau, Emmanuel Nony
  • Method for treating infectious disease using monoclonal antibodies
    Patent number: 8178093
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fc? receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: May 15, 2012
    Assignee: LFB Biotechnologies
    Inventors: Roland Beliard, Dominique Bourel, Amaud Glacet, Christophe de Romeuf, Nicolas Bihoreau, Emmanuel Nony
  • Method for treating cancer using monoclonal antibodies
    Patent number: 8153124
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fc? receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: April 10, 2012
    Assignee: LFB Biotechnologies
    Inventors: Roland Beliard, Dominique Bourel, Amaud Glacet, Christophe de Romeuf, Nicolas Bihoreau, Emmanuel Nony
  • METHOD FOR TREATING INFECTIOUS DISEASE USING MONOCLONAL ANTIBODIES
    Publication number: 20110059073
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fc? receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).
    Type: Application
    Filed: July 14, 2009
    Publication date: March 10, 2011
    Inventors: ROLAND BELIARD, DOMINIQUE BOUREL, AMAUD GLACET, CHRISTOPHE DE ROMEUF, NICOLAS BIHOREAU, EMMANUEL NONY
  • Anti-rhesus D monoclonal antibodies
    Patent number: 7541029
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby of for uses such as idiopathic thrombocytopenic pupura (ITP).
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: June 2, 2009
    Assignee: Laboratoire Francais du Fractionnement et des Biotechnologies
    Inventors: Roland Beliard, Dominique Bourel, Amaud Glacet, Christophe de Romeuf, Nicolas Bihoreau, Emmanuel Nony